Patent · US Active

RG1 antibodies and uses thereof

US7608263B2 · kind B2 · utility

0Cited by
10References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 30, 2007
Grant dateOct 27, 2009
Priority date
Expiry dateOct 30, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/56
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to antibodies, and antigen-binding antibody fragments, directed against an RG1 polypeptide. The invention further relates to methods for utilizing the antibodies, and antibody fragments, for diagnostic and therapeutic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.